WILMINGTON, Del. - Bankrupt Savient Pharmaceuticals Inc. on April 18 moved in the U.S. Bankruptcy Court for the District of Delaware for approval of a settlement deal in which a creditor's claim would be reduced by $68,849.98 to avoid "needless litigation" (In Re: Savient Pharmaceuticals Inc., No. 13-12680, Chapter 11, D. Del. Bkcy.).